Boston Partners Kala Pharmaceuticals, Inc. Transaction History

Boston Partners

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$3.83 - $8.79 $536,073 - $1.23 Million	-139,967 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$3.36 - $4.81 $53,534 - $76,637	15,933 Added 12.85%	139,967 $516,000
Q3 2019 Nov 20, 2019	BUY	$3.57 - $6.58 $20,002 - $36,867	5,603 Added 4.73%	124,034 $472,000
Q2 2019 Aug 09, 2019	BUY	$4.93 - $8.8 $493,000 - $880,000	100,000 Added 542.56%	118,431 $756,000
Q1 2019 May 03, 2019	BUY	$5.19 - $8.97 $95,656 - $165,326	18,431 New	18,431 $152,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $10.5M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

Stay updated on Boston Partners with notifications on news.